MedTrace Logo

Data Collection Registry of the HeRO Graft for End Stage Renal Disease Patients Receiving Hemodialysis

NCT02164175 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2021-05-10

No results posted yet for this study

Summary

Data Collection Registry of the HeRO Graft for End Stage Renal Disease Patients Receiving Hemodialysis

Conditions

  • End Stage Renal Failure on Dialysis

Interventions

DEVICE

HeRO Graft implant for dialysis access

End Stage Renal Disease patients who receive HeRO Graft implant for dialysis access

Sponsors & Collaborators

  • CryoLife, Inc.

    collaborator INDUSTRY

  • Merit Medical Systems, Inc.

    lead INDUSTRY

Principal Investigators

  • Jeffrey Lawson, MD · Duke University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2018-12-31
Completion
2023-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02164175 on ClinicalTrials.gov